Granulocyte-Macrophage Colony-Stimulating Factor: Another Cytokine With Adjuvant Therapeutic Benefit in Melanoma?
- 8 April 2000
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (8) , 1603-1605
- https://doi.org/10.1200/jco.2000.18.8.1603
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating FactorJournal of Clinical Oncology, 2000
- Regression of In-Transit Melanoma of the Scalp With Intralesional Recombinant Human Granulocyte-Macrophage Colony-Stimulating FactorArchives of Dermatology, 1999
- PHASE I TRIAL OF ADJUVANT VACCINATION WITH TYROSINASE PEPTIDES AND GM-CSF IN MELANOMAJournal of Immunotherapy, 1999
- Dendritic CellsPublished by Elsevier ,1999
- Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptidesin vivoInternational Journal of Cancer, 1996
- Clinical responses and lymphoid infiltrates in metastatic melanoma following treatment with intralesional GM-CSFMelanoma Research, 1996
- Monocyte Activation Following Systemic Administration of Granulocyte-Macrophage Colony-Stimulating FactorJournal of Immunotherapy, 1994
- Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Proceedings of the National Academy of Sciences, 1993
- HLA-DR antigens in normal, inflammatory, and neoplastic salivary glandsOral Surgery, Oral Medicine, Oral Pathology, 1987
- Induction of Macrophage Tumoricidal Activity by Granulocyte-Macrophage Colony-Stimulating FactorScience, 1986